|
Genentech Inc. News is an EIN News Service for health professionals. Constantly updated news and information about health.
Latest Genentech Inc. News
- BLOG: The Platform: Costly new drugs: A crisis for one family, a quandry for U.S. [St. Louis Post-Dispatch] 7 Nov 2009 18:37 GMT
... who received Avastin. After 18 months, 13 were alive. The company that makes Avastin, Genentech, spent about $2.25 billion to develop it. It spends another $1 billion a year ...
- Nation's Capital Hosts Gala to Raise Funds for Melanoma Research 7 Nov 2009 01:42 GMT
... Bowl package, and wines from some of the world’s top vineyards. Corporate sponsors include Genentech, Roche, Merrill Lynch, and Morgan Stanley, among others. All proceeds from the event will ...
- IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 1-5, 2010 in Carls 7 Nov 2009 17:51 GMT
... Company -- Industrialization of mAb Production - Implications, Challenges and Opportunities Dana Anderson, Ph.D., Genentech, Inc. -- Manufacturing Synagis: Life Cycle Management of a Life Saving Antibody Jeffrey Baker, ...
- Microsoft Office Battles Google in the Cloud 7 Nov 2009 00:59 GMT
... only ones using Google Apps; the company counts some major enterprises, such as Motorola, Genentech and Sabic (formerly GE Plastics), as customers, all of which have tens of thousands ...
- MMR Information Systems Engages Global Research Services as Advisor to Accelerate Time to Market for 7 Nov 2009 19:14 GMT
... marketed under the trade name Rituxan® in the United States by Biogen Idec and Genentech (wholly owned member of the Roche Group) and under the name MabThera® by Roche ...
- Affitech Announces New Scientific Findings for its r84 Fully Human VEGF/VEGFR2 Selective Antibody 6 Nov 2009 12:52 GMT
... information is available at www.affitech.com. Avastin® and Sutent® are tradenames and/or trade marks of Genentech Inc., and Pfizer Inc., respectively Copyright © 2009 OMX AB (publ). ...
- New Options for Treatment of RA and Lupus are Focus of Rheumatology Thought Leader Panel 6 Nov 2009 15:48 GMT
... (belimumab) in systemic lupus erythemetosis (SLE). Impact of the FDA's complete response letter rejecting Genentech's application for Rituxan (rituximab) in RA patients who have previously failed DMARD therapy - ...
- Volunteering can be powerful 'medicine' 6 Nov 2009 04:36 GMT
... visit www.handinhandforRA.com. Hand In Hand for RA is a national awareness campaign developed by Genentech and Biogen Idec with the grassroots advocacy group CreakyJoints. Courtesy of ARAcontent ...
- TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients 6 Nov 2009 08:17 GMT
... breast cancer spreads or metastasizes, it crashes through the body's protective fences. The dis... Genentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that ...
- NeurogesX Reports Third Quarter 2009 Results 6 Nov 2009 12:50 GMT
... veteran that has held various senior executive positions at Novacea, Inc., Collabra Pharma, and Genentech, Inc. Anthony DiTonno, President and CEO, commented, "The NeurogesX team continues to operate at ...
- MS Office battles Google in the cloud 6 Nov 2009 17:51 GMT
... only ones using Google Apps; the company counts some major enterprises, such as Motorola, Genentech and Sabic (formerly GE Plastics), as customers, all of which have tens of thousands ...
- MS Office battles growing threat from Google in the cloud 6 Nov 2009 18:31 GMT
... only ones using Google Apps; the company counts some major enterprises, such as Motorola, Genentech, and Sabic (formerly GE Plastics), as customers, all of which have tens of thousands ...
- CED Sets Dates for Upcoming Conference Season 6 Nov 2009 18:35 GMT
... Inc.; Nicole Fouché, executive director of Triangle Global Health Consortium; Steve Krognes, CFO of Genentech, Inc.; Ernest Mario, Ph.D., formerly of GlaxoSmithKline, Alza Corporation and Reliant Pharmaceuticals; J. Michael ...
- Medicare reverses billing change on Genentech drug 5 Nov 2009 18:32 GMT
... 2009 / Updated: Wednesday, Oct. 28, 2009 02:56 PM Medicare reverses billing change on Genentech drug Medicare officials are backing off a policy that pushed many doctors to use ...
- Roche Opens Singapore Manufacturing Facility for Projects Initiated by Genentech 5 Nov 2009 09:23 GMT
... the other will make Avastin, a targeted cancer therapy. Both projects were initiated by Genentech, now a wholly owned subsidiary of Roche. The project, which operates under the name ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
bbc.co.uk:
healthday.com:
reuters.com: